July 10 (Reuters) - The U.S. Federal Trade Commission is
planning to sue UnitedHealth ( UNH ) , Cigna ( CI ) and CVS
Health ( CVS ), the three largest pharmacy-benefit
managers, over their tactics for negotiating prices for drugs
including insulin, the Wall Street Journal reported on
Wednesday, citing a person familiar with the matter.